<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60426">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01948635</url>
  </required_header>
  <id_info>
    <org_study_id>2013 A00534 41</org_study_id>
    <nct_id>NCT01948635</nct_id>
  </id_info>
  <brief_title>Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care Units</brief_title>
  <acronym>BestCuff</acronym>
  <official_title>Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care Units</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesized that PVC tapered-cuff tracheal tubes would reduce
      microaspiration of gastric content as determined by pepsin level in tracheal aspirate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Microaspiration is the main route for entry of contaminated secretions into the lower
      respiratory tract of intubated critically ill patients. Tracheobronchial colonization might
      progress to ventilator-associated pneumonia (VAP) when the quantity and virulence of
      bacteria are high and when local and general host defenses are weak.

      Recent in vitro and animal studies suggest that tapered-cuff tracheal tubes could be
      associated with reduced microaspiration of contaminated secretions and might be helpful in
      preventing VAP.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Microaspiration of gastric contents</measure>
    <time_frame>48 hours after randomization</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mesuerment of pepsin level in tracheal aspirate will be used to quantify microaspiration of gastric contents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microaspiration of oropharyngeal secretions</measure>
    <time_frame>48 h after randomization</time_frame>
    <safety_issue>No</safety_issue>
    <description>amylase level on tracheal aspirate would allow to quantify microaspiration of oropharyngeal secretions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tracheobronchial colonization</measure>
    <time_frame>28 days after randomization</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-associated pneumonia</measure>
    <time_frame>28 days after randomization</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Critical Illness</condition>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Ventilator Associated Pneumonia</condition>
  <arm_group>
    <arm_group_label>tapered PVC-cuffed tracheal tubes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will be intubated with tapered PVC-tracheal tubes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard PVC-cuffed tracheal tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will be intubated with standard (barrel-shape cuffed) PVC tracheal tubes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tapered PVC-cuffed tracheal tubes</intervention_name>
    <description>Patients will be intubated with tapered-shape tracheal tubes</description>
    <arm_group_label>tapered PVC-cuffed tracheal tubes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard PVC-cuffed tracheal tube</intervention_name>
    <description>Patients will be intubated with standard PVC cuffed tracheal tubes</description>
    <arm_group_label>Standard PVC-cuffed tracheal tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; or = 18 years

          -  tracheal intubation

          -  predictable duration of mechanical ventilation &gt; 48h

          -  enteral nutrition

        Exclusion Criteria:

          -  pregnant women

          -  refuse to participate to the study

          -  no informed consent

          -  contre indication for semirecumbent position
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saad Nseir, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU de Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>NSEIR Saad, MD</last_name>
    <phone>+33320444084</phone>
    <email>saad.nseir@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>ICU, Salengro Hospital, University Hospital of Lille</name>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <zip>59035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NSEIR Saad, MD</last_name>
      <phone>+33320444084</phone>
      <email>saad.nseir@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuelle Jaillette, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 1, 2014</lastchanged_date>
  <firstreceived_date>August 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Lille</investigator_affiliation>
    <investigator_full_name>Saad NSEIR</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>tracheal cuff shape</keyword>
  <keyword>microaspiration</keyword>
  <keyword>pepsin</keyword>
  <keyword>ventilator-associated pneumonia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
